Ariad Pharma (ARIA) Commences Common Stock Offering

January 23, 2013 4:24 PM EST Send to a Friend
Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA) has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by ARIAD.

J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the proposed offering. ARIAD intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the amount sold to cover over-allotments, if any. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

JPMorgan, Jefferies & Co, Cowen & Co

Add Your Comment